Date: 26 – 27 Nov 2026
Time: 9:00 am – 6:00 pm
Venue: Charles K. Kao Auditorium, HKSTP
InnoHK ABIC Global Summit 2026: AI-Powered and Biomedical Breakthroughs Bridging Industry and Capital Markets convenes leading experts from academia, industry, clinical practice, and investment communities to advance high-level exchanges at the intersection of AI-powered biomedical innovation and industrial translation. The Summit will feature keynote speeches, thematic panels, round-table discussions, and strategic presentations addressing critical topics such as AI-driven translational medicine, industrial-academic collaboration, regulatory and commercialization pathways, and emerging biomedical technologies.
No Registration Fee
International speakers
Prof. Anderson Shum, MH
Chair Professor
Department of Mechanical Engineering and School of Biomedical Engineering
Vice-President and Pro-Vice-Chancellor (Research)
The University of Hong Kong
Founding Centre Director and Co-Director
Advanced Biomedical Instrumentation Centre
Vice-President and Pro-Vice-Chancellor (Research)
The University of Hong Kong
Founding Centre Director and Co-Director
Advanced Biomedical Instrumentation Centre
Prof. Paddy Chan
Associate Professor
Department of Mechanical Engineering
The University of Hong Kong
Managing Director and Centre Co-Director
Advanced Biomedical Instrumentation Centre
The University of Hong Kong
Managing Director and Centre Co-Director
Advanced Biomedical Instrumentation Centre
Prof. Andreas Bausch
Heinz Nixdorf Chair in Biophysical Engineering of Living Matter
TUM School of Natural Sciences
Technical University of Munich
Technical University of Munich
Prof. Gonçalo Bernardes
Professor of Chemical Biology
Yusuf Hamied Department of Chemistry
University of Cambridge
University of Cambridge
Prof. Joseph Chan
Associate Professor
Department of Ophthalmology
The University of Hong Kong
The University of Hong Kong
Prof. Aviva Chow
Associate Professor
Department of Pharmacology and Pharmacy
The University of Hong Kong
The University of Hong Kong
Prof. Liang-Yin Chu
Professor
School of Chemical Engineering
Executive Vice President
Sichuan University
Executive Vice President
Sichuan University
Prof. Xuexin Duan
Full Professor
College of Precision Instrument and Opto-electronics Engineering
Tianjin University
Tianjin University
Prof. Shery Huang
Professor of Bioengineering
Department of Engineering
University of Cambridge
University of Cambridge
Prof. Dayong Jin
Distinguished Professor
Institute for Biomedical Materials & Devices (IBMD)
University of Technology Sydney
University of Technology Sydney
Prof. Maximilian Reichert
Professor for Translational Pancreatic Cancer Research
TUM School of Medicine and Health
Technical University of Munich
Technical University of Munich
Prof. Julian Tanner
Professor
LKS Faculty of Medicine
The University of Hong Kong
The University of Hong Kong
Prof. Kevin Tsia
Professor
Department of Electrical and Computer Engineering
The University of Hong Kong
The University of Hong Kong
Prof. Lei Xu
Professor
Department of Physics
The Chinese University of Hong Kong
The Chinese University of Hong Kong
Prof. David Weitz
Mallinckrodt Professor of Physics and of Applied Physics
Department of Physics
Harvard University
Harvard University
Prof. Ryuji Yokokawa
Professor
Department of Micro Engineering
Kyoto University
Kyoto University
Prof. Nanjia Zhou
Professor
School of Engineering
Westlake University
Westlake University
Prof. Hee-Sun Han
Associate Professor Department of Chemistry
University of Illinois at Urbana-Champaign
AI Experts
Prof. Xin Gao
Professor, Computer Science
Computer, Electrical and Mathematical Science and Engineering Division
King Abdullah University of Science & Technology
King Abdullah University of Science & Technology
Dr. Charleston Sin
Head of AI and Data
Hong Kong Science and Technology Park
Prof. Juexiao Zhou
Assistant Professor
School of Data Science
The Chinese University of Hong Kong, Shenzhen
The Chinese University of Hong Kong, Shenzhen
Industry & Capital Markets Leaders
Mr. Terry Wong
Chief Executive Officer
Hong Kong Science and Technology Park
Mr. Collin Lau
Co-Founder and Group CEO
Virtus Medical Group
Mr. Clarence Tan
Founder and CEO
Origgin Capital
Dr. Adrian Cheong
Specialist in Cardiology and Partner
Virtus Medical Group
Mr. Leslie Chow
Chief Financial Officer
PHASE Scientific International Limited
Mr. Fred Li
Managing Director
Gobi Partners
Dr. Glorian Qi
Director
Innovation and Translational Research Life and Health Technology,
HKSTP
HKSTP
Mr. James Yip
Chief of Clinical Translation
Virtus Medical Group
Mr. Tony Yung
Chief Commercial Officer
Advanced Biomedical Instrumentation Centre
Mr. Rock Deng
Partner
Sherpa Healthcare Partners
Dr. Abby Gao
Deputy Head & Director of Investment Research
DEFTA Partners
Dr. Lily Siying Ma
Investment Director
Investment Department,
SIIC Capital (Hong Kong) Limited /
Hong Kong Biotech Fund
SIIC Capital (Hong Kong) Limited /
Hong Kong Biotech Fund
Rundown
| 26 Nov 2026 (Day 1) | |||
|---|---|---|---|
| 09:00 – 9:45 Opening Session |
09:00 | Registration | |
| 9:20 | Welcoming Address (HKSTP Representative, HKSTP CEO) Opening Speech Welcoming Remarks (Conference Chair: Prof. Anderson Shum) |
||
| 9:45 – 10:05 | 9:45 | MoU Signing Ceremony |
Collaboration with Virtus Medical Group Signing Ceremony Dr. CC Luk, Vice Chairman and Chief Medical Officer, Virtus Medical Group Mr. Collin Lau, Co-Founder – Virtus Medical Group |
| 10:05 – 11:05 Session 1 Keynote Speech |
10:05 | Keynote Speech 1 | Prof. Zhigang Suo |
| 10:35 | Keynote Speech 2 | Controllable Fabrication of Biomedical Microstructured Functional Materials using Microfluidic Technology Prof. Liangyin Chu |
|
| 11:05 – 12:35 Session 2 High-Precision Instruments for Clinical Science |
11:05 | Talk 1 | Building Digital Twin of Cells from a Street View of Organelles and Cellular Networks Prof. Dayong Jin |
| 11:35 | Talk 2 | GHz Hypersonic Acoustic Streaming for Precision Biofabrication and Biomedical Instrumentation Prof. Xuexin Duan |
|
| 12:35 – 13:45 Break | |||
| 14:00 – 15:35 Session 3 Capital Markets and Investments – From Asia to Global for Bioengineering |
14:00 | Opening Session | Opening Remarks (Prof. Paddy Chan) |
| 14:05 | Panel Discussion 1 | Investing in the Future of AI-Powered Biomedicine: What Makes a Fundable Breakthrough? Panelists: Mr. Collin Lau, Mr. Clarence Tan, Ms. Lily Ma Moderator: Mr. Tony Yung |
|
| 14:50 | Panel Discussion 2 | From Venture to IPO: Capital Markets Strategies for AI-Driven Biomedical Companies Panelists: Mr. Leslie Chow, Dr. Adrian Cheong, Dr. Abby Gao Moderator: Mr. James Yip |
|
| 15:35 – 18:00 Session 4 AI in Health & Life Sciences |
15:35 | Panel Discussion 3 Powered by HKSTP AI Biotech Division |
Artificial Intelligence for Life Sciences and Healthcare Moderator: Dr. Charleston Sin |
| 16:20 | Talk 3 | Trustworthy, Explainable and Ethical Intelligent Healthcare Prof. Juexiao Zhou |
|
| 17:30 | Talk 4 | AI-driven Peptide Drug Development Prof. Xin Gao |
|
| 18:00 – 18:05 Closing Session |
18:00 – 18:05 | Closing Remarks of Day 1 End of Day 1 |
|
| 27 Nov 2026 (Day 2) | |||
| 09:30 – 09:50 Opening Session |
09:30 | Registration | |
| 09:45 | Welcoming Remarks (Prof. David Weitz) | ||
| 09:50 – 10:20 Session 5 Keynote Speech |
9:50 | Keynote Speech 3 | Drop-based microfluidics for biotech applications Prof. David Weitz |
| 10:20 – 12:20 Session 6 Organoid and Micro-physiological Systems |
10:20 | Talk 5 | Prof. Andreas Bausch |
| 10:50 | Talk 6 | Patient-Derived Organoids in Pancreatic Cancer – Translating Tumor Complexity into Therapeutic Opportunities Prof. Maximilian Reichert |
|
| 11:20 | Talk 7 | Vascular Microphysiological Systems (MPS) Integrating iPSC-Derived Organoids and Tumor Microenvironments for Disease Modeling and Drug Assessment Prof. Ryuji Yokokawa |
|
| 11:50 | Talk 8 | Biofabrication x AI for Translational Bioengineering Prof. Shery Huang |
|
| 12:20 – 13:30 Break | |||
| 14:15 – 15:45 Session 7 Novel Materials for Bioengineering |
13:45 | Talk 9 | Engineering Biological Systems: From Scalable Diagnostics to Controlled Perturbations Prof. Hee-Sun Han |
| 14:15 | Talk 10 | Precision Electronic Additive Manufacturing: Materials, Equipment, and Applications Prof. Nanjia Zhou |
|
| 14:45 | Talk 11 | Translational Chemical Biology Prof. Gonçalo Bernardes |
|
| 15:15 | Talk 12 | A Platform Technology for Drug Solubility Enhancement Based on Competitive Adsorption Prof. Lei Xu |
|
| 15:45 – 18:15 Session 8 Industry-oriented Innovation cum Pitching Corner (Final Round) |
Time | Scientific Content | Spin-off's Commercialization Plan |
| 15:45 | Session Opening | Session Introduction (By Session Chair: Mr. Tony Yung) Expert Advisory Panel: Mr. Rock Deng Mr. Fred Li Dr. Shaolin Liang Dr. Glorian Qi Mr. James Yip |
|
| 15:50 | Engineering Deep Biophysical Cytometry: Decoding Cell State Beyond Molecules Prof. Kevin Tsia |
Dr. Michelle Lo CEO of AxileLife |
|
| 16:25 | Nose-to-Brain Drug Delivery for Advancing Management of Neurological Disorders Prof. Aviva Chow |
Dr. Zitong Shao CEO of CereThera |
|
| 17:00 | Biosensing and Diagnostics in an AI World Prof. Julian Tanner |
Dr. Wang Lin CEO of LifeSpectrum |
|
| 17:35 | From Infection to Cancer: An All-in-one Simple Treatment Strategy to Tackle Various Ocular Surface Diseases Prof. Joseph Chan |
Mr. Daniel Ng CEO of IVECS |
|
| 18:15 – 18:20 Closing Session |
18:15 – 18:20 | Closing Remarks End of the Summit |
|
Co-organizer:
